CRLX101 is a novel approach to cancer chemotherapy that is currently under investigation in human trials, and is an example of a nanomedicine.
CRLX101 is a novel approach to cancer chemotherapy. This novel approach to cancer chemotherapy is currently under investigation in human trials. This novel approach to cancer chemotherapy is an example of a nanomedicine.